Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Cancer Treatment Reviews
|
May 7, 2023
Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treatm. Rev. 114 (2023) 102511]
F Miglietta, A Fabi, D Generali, et al.
International Angiology : a Journal of the International Union of Angiology
|
February 26, 2014
Diagnosis and Treatment of Venous Malformations. Consensus Document of the International Union of Phlebology (IUP): updated 2013
B B Lee, I Baumgartner, P Berlien, et al.
International Angiology : a Journal of the International Union of Angiology
|
June 26, 2014
Guideline. Diagnosis and treatment of venous malformations. consensus document of the international union of phlebology (iup): updated-2013
B B Lee, I Baumgartner, P Berlien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial
G Bianchini, L Pusztai, T Pienkowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2022
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
L Gianni, C S Huang, D Egle, et al.
International Angiology : a Journal of the International Union of Angiology
|
February 26, 2013
Consensus Document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio-venous management
B B Lee, I Baumgartner, H P Berlien, et al.
International Angiology : a Journal of the International Union of Angiology
|
July 11, 2015
Vascular Anomalies Guidelines by the Italian Society for the study of Vascular Anomalies (SISAV)
F Stillo, V Baraldini, P Dalmonte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2025
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy
E L Mayer, F-C Bidard, Y H Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2024
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer
R Dent, F André, A Gonçalves, et al.
Journal of Medical Genetics
|
August 25, 2005
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment
A Del Fattore, B Peruzzi, N Rucci, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Cancer Treatment Reviews
|
May 7, 2023
Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treatm. Rev. 114 (2023) 102511]
F Miglietta, A Fabi, D Generali, et al.
International Angiology : a Journal of the International Union of Angiology
|
February 26, 2014
Diagnosis and Treatment of Venous Malformations. Consensus Document of the International Union of Phlebology (IUP): updated 2013
B B Lee, I Baumgartner, P Berlien, et al.
International Angiology : a Journal of the International Union of Angiology
|
June 26, 2014
Guideline. Diagnosis and treatment of venous malformations. consensus document of the international union of phlebology (iup): updated-2013
B B Lee, I Baumgartner, P Berlien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial
G Bianchini, L Pusztai, T Pienkowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2022
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
L Gianni, C S Huang, D Egle, et al.
International Angiology : a Journal of the International Union of Angiology
|
February 26, 2013
Consensus Document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio-venous management
B B Lee, I Baumgartner, H P Berlien, et al.
International Angiology : a Journal of the International Union of Angiology
|
July 11, 2015
Vascular Anomalies Guidelines by the Italian Society for the study of Vascular Anomalies (SISAV)
F Stillo, V Baraldini, P Dalmonte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2025
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy
E L Mayer, F-C Bidard, Y H Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2024
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer
R Dent, F André, A Gonçalves, et al.
Journal of Medical Genetics
|
August 25, 2005
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment
A Del Fattore, B Peruzzi, N Rucci, et al.
Page
of 10